Abstract:ctive: Benzothiazole and imidazo[2,1- b ][1,3,4]thiadiazole derivatives are the most important pharmacophores and intermediates for making drugs. This study focuses on the preparation and anti-cancer activity of novel benzothiazole-based imidazo[2,1- b ][1,3,4]thiadiazole scaffolds. Methods: The synthesized benzothiazolebased imidazo[2,1- b ][1,3,4]thiadiazole scaffolds ( Va–Vi ) were evaluated. The anticancer activity of ( Va–Vi ) against MCF-7 and A549 cell lines was determined using the MTT assay and screened with in silico molecular docking studies. Results and Discussion: Compounds 2-(6-(4-chlorophenyl)imidazo[2,1- b ][1,3,4]thiadiazol-2-yl)benzo[ d ]thiazole ( Vb ), 2-(6-(4-bromophenyl)imidazo[2,1- b ][1,3,4]thiadiazol-2-yl)benzo[ d ]thiazole ( Vd ), and 2-(6-(4nitrophenyl)imidazo[2,1- b ][1,3,4]thiadiazol-2-yl)benzo[ d ]thiazole ( Vh ) exhibited the most potent anticancer activity against MCF-7 and A549 cancer cell lines. Molecular docking studies of all synthesized compounds and erlotinib were also carried out on the EGFR receptor, showing that compounds ( Vb ), ( Vd ), and ( Vh ) had significantly higher binding scores and inhibitory constants than the reference drug erlotinib. Conclusions: It has been observed that the substitution on the 4-chlorophenyl ring ( Vb ), 4-bromophenyl ring ( Vd ), and 4-nitrophenyl ring ( Vh ) is important for maintaining their anticancer activity. The outcomes of the kinase inhibitory assay of these significant ( Vb ), ( Vd ), and ( Vh ) hybrids against the tyrosine kinase EGFR strongly corroborated the in vitro anticancer findings and the in silico docking investigations. The investigation demonstrated that the newly synthesized compounds have the potential as anticancer agents and provided leads for further development.

Synthesis and Anticancer Evaluation of Isoxazole Ring-Containing 6-(Pyridin-4-yl)imidazo[2,1-b][1,3]thiazole Derivatives

Synthesis, Crystal Structure and Evaluation of Cancer Inhibitory Activity of 4-[Indol-3-yl-methylene]-1h-pyrazol-5(4h)-one Derivatives

Synthesis and biological evaluation of tetrazole ring incorporated oxazole-pyrimidine derivatives as anticancer agents

Design, Synthesis and Biological Evaluation of Amide Derivatives of Thiazole-Indole-Isoxazoles as Anticancer Agents

Synthesis and anticancer activity evaluation of some novel imidazo[1,2-a]pyridine based heterocycles containing S-alkyl/aryl moiety

Synthesis and biological evaluation of aryl derivatives of indole-1,3,4-thiadiazole as anticancer agents

Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-A] Pyridine Derivatives

Design And Synthesis Of Novel Thiazole Linked Tetrahydropyridine Analogues As Anticancer Agents

Synthesis and Evaluation of In-vitro Anticancer Activity of Novel Pyrimidine Derivatives

Synthesis and Anticancer Activity of Some New Pyrazolo[3,4-d]pyrimidin-4-one Derivatives

Novel 5-Methyl-2-[(un)substituted Phenyl]-4-{4,5-Dihydro-3-[(Un)Substituted Phenyl]-5-(1,2,3,4-Tetrahydroisoquinoline-2-Yl)Pyrazol-1-Yl}-Oxazole Derivatives: Synthesis and Anticancer Activity

Design, Synthesis, Anticancer Evaluation and Molecular Docking Study of Novel 4H‐Chromene‐7‐Azaindole‐1,2,3‐Triazole Hybrids

Design, Synthesis and Biological Evaluation of Amide Derivatives of Thiazolo[5,4-d]Pyrimidines as Cytotoxicity Agents for Human Cancer Cell Lines

Synthesis and in vitro and in vivo anticancer activity of novel phenylmethylene bis-isoxazolo[4,5-b]azepines

Synthesis and Biological Evaluation of Novel Pyrazoline Derivatives Containing Indole Skeleton As Anti-Cancer Agents Targeting Topoisomerase II.

Synthesis and antiproliferative potency of 1,3,4-thiadiazole and 1,3-thiazolidine-4-one based new binary heterocyclic molecules: in vitro cell-based anticancer studies

Novel 5-(3-(substituted)-4,5-dihydroisoxazol-5-yl)-2-methoxyphenyl Derivatives: Synthesis and Anticancer Activity

Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents.

Synthesis and biological evaluation of 1, 2, 3-triazole incorporated pyrrole derivatives as anticancer agents

Synthesis and Biological Evaluation of 2-(6-Phenylimidazo[2,1-b][1,3,4]thiadiazol-2-yl)benzo[d]thiazole Derivatives as EGFR Targeting Anticancer Agents

Synthetic strategies and anticancer evaluation for the novel 3-(6-heteroaryltriazolo[3,4-b][1,3,4]thiadiazol-3-yl)chromeno [2,3-b]pyridines